Identification of Potential SARS-CoV-2 CD8 T Cell Escape Mutants.

Syed Faraz Ahmed, Muhammad Saqib Sohail, Ahmed Abdul Quadeer, Matthew R McKay
Author Information
  1. Syed Faraz Ahmed: Department of Electrical and Electronic Engineering, University of Melbourne, Parkville, VIC 3010, Australia. ORCID
  2. Muhammad Saqib Sohail: Department of Electronic and Computer Engineering, The Hong Kong University of Science and Technology, Hong Kong SAR, China. ORCID
  3. Ahmed Abdul Quadeer: Department of Electronic and Computer Engineering, The Hong Kong University of Science and Technology, Hong Kong SAR, China. ORCID
  4. Matthew R McKay: Department of Electrical and Electronic Engineering, University of Melbourne, Parkville, VIC 3010, Australia. ORCID

Abstract

Memory SARS-CoV-2-specific CD8 T cell responses induced upon infection or COVID-19 vaccination have been important for protecting against severe COVID-19 disease while being largely robust against variants of concern (VOCs) observed so far. However, T cell immunity may be weakened by genetic mutations in future SARS-CoV-2 variants that lead to widespread T cell escape. The capacity for SARS-CoV-2 mutations to escape memory T cell responses requires comprehensive experimental investigation, though this is prohibited by the large number of SARS-CoV-2 mutations that have been observed. To guide targeted experimental studies, here we provide a screened list of potential SARS-CoV-2 T cell escape mutants. These mutants are identified as candidates for T cell escape as they lie within CD8 T cell epitopes that are commonly targeted in individuals and are predicted to abrogate HLA-peptide binding.

Keywords

References

  1. Sci Immunol. 2021 Mar 4;6(57): [PMID: 33664060]
  2. Mol Biol Evol. 2013 Apr;30(4):772-80 [PMID: 23329690]
  3. Med. 2021 Jun 11;2(6):682-688.e4 [PMID: 33851143]
  4. Viruses. 2022 Jan 02;14(1): [PMID: 35062283]
  5. Nucleic Acids Res. 2020 Jul 2;48(W1):W449-W454 [PMID: 32406916]
  6. Cell. 2021 Dec 22;184(26):6229-6242.e18 [PMID: 34910927]
  7. Immunity. 2013 Mar 21;38(3):425-36 [PMID: 23521884]
  8. Cell. 2022 Aug 4;185(16):2936-2951.e19 [PMID: 35931021]
  9. Adv Drug Deliv Rev. 2021 Apr;171:29-47 [PMID: 33465451]
  10. Viruses. 2021 Aug 25;13(9): [PMID: 34578269]
  11. Semin Immunol. 2011 Apr;23(2):84-91 [PMID: 21306912]
  12. Cell Rep Med. 2021 Jul 20;2(7):100355 [PMID: 34230917]
  13. Cell. 2020 Nov 12;183(4):996-1012.e19 [PMID: 33010815]
  14. Annu Rev Immunol. 2020 Apr 26;38:123-145 [PMID: 32045313]
  15. Cell. 2022 Mar 17;185(6):1041-1051.e6 [PMID: 35202566]
  16. Nature. 2022 Feb;602(7898):671-675 [PMID: 35016199]
  17. Nat Immunol. 2022 Feb;23(2):186-193 [PMID: 35105982]
  18. N Engl J Med. 2021 May 13;384(19):1866-1868 [PMID: 33761203]
  19. Nat Med. 2021 May;27(5):917-924 [PMID: 33772244]
  20. Cell Rep Med. 2021 Jun 15;2(6):100312 [PMID: 34056627]
  21. Nature. 2022 Mar;603(7901):488-492 [PMID: 35102311]
  22. BMC Bioinformatics. 2006 Mar 17;7:153 [PMID: 16545123]

Grants

  1. 16213121/General Research Fund of the Hong Kong Research Grants Council (RGC)

Word Cloud

Created with Highcharts 10.0.0TcellSARS-CoV-2escapemutationsCD8COVID-19variantsresponsesconcernobservedexperimentaltargetedmutantsepitopesMemorySARS-CoV-2-specificinduceduponinfectionvaccinationimportantprotectingseverediseaselargelyrobustVOCsfarHoweverimmunitymayweakenedgeneticfutureleadwidespreadcapacitymemoryrequirescomprehensiveinvestigationthoughprohibitedlargenumberguidestudiesprovidescreenedlistpotentialidentifiedcandidatesliewithincommonlyindividualspredictedabrogateHLA-peptidebindingIdentificationPotentialCellEscapeMutantsCD8+immuneimmunoprevalent

Similar Articles

Cited By